Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/16019552

Download in:

View as

General Info

PMID
16019552